title: Antithrombotic therapy in cardiac disease. An emerging approach based on pathogenesis and risk.
authors.affiliation: Mount Sinai Medical Center, New York, New York 10029.
authors.forename: B
authors.initials: B
authors.lastname: Stein
authors.forename: V
authors.initials: V
authors.lastname: Fuster
authors.forename: J L
authors.initials: JL
authors.lastname: Halperin
authors.forename: J H
authors.initials: JH
authors.lastname: Chesebro
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D000925:Anticoagulants / Q000627:therapeutic use*; D001026:Coronary Artery Bypass; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006331:Heart Diseases / Q000150:complications*; D006350:Heart Valve Prosthesis / Q000009:adverse effects; D006801:Humans; D011292:Premedication; D012307:Risk Factors; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents